Sanctions Imposed in Valsartan Recall Lawsuits Over Drug Maker’s Discovery Violations
Judge hopes Valsartan recall lawsuit sanctions over discovery failures will serve as a deterrent to other foreign companies considering disregard for U.S. laws.
Tag Archives: Hetero Labs
-
-
More Than 1,200 Valsartan Lawsuits Pending in MDL Over Cancers Caused By Recalled Blood Pressure Drug
A joint report recommends that the first valsartan recall lawsuit be set to go before a jury in Fall 2024, after a prior trial scheduled to begin in March was postponed when the judge presiding over the litigation retired.
-
Valsartan Settlements Reached To Resolve Personal Injury, Class Action and Medical Monitoring Claims Against Hetero
Lawyers will seek preliminary approval for a settlement of valsartan lawsuits against the generic drug maker Hetero, but claims involving other manufacturers of contaminated valsartan pills remain unresolved
-
Following Zantac Problems and Recalls, GlaxoSmithKline Sells Manufacturing Plant In India For Fraction Of Value
